The DVAX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the DVAX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The DVAX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View DVAX Detailed Price Forecast - CNN Money||View DVAX Detailed Summary - Google Finance|
|View DVAX Detailed Summary - Yahoo! Finance||View DVAX Stock Research & Analysis - Zacks.com|
|View DVAX Trends & Analysis - Trade-Ideas||View DVAX Major Holders - Barrons|
|View DVAX Call Transcripts - NASDAQ||View DVAX Breaking News & Analysis - Seeking Alpha|
|View DVAX Annual Report - CompanySpotlight.com||View DVAX OTC Short Report - OTCShortReport.com|
|View DVAX Fundamentals - TradeKing||View DVAX SEC Filings - Bar Chart|
|View Historical Prices for DVAX - The WSJ||View Performance/Total Return for DVAX - Morningstar|
|View the Analyst Estimates for DVAX - MarketWatch||View the Earnings History for DVAX - CNBC|
|View the DVAX Earnings - StockMarketWatch||View DVAX Buy or Sell Recommendations - MacroAxis|
|View the DVAX Bullish Patterns - American Bulls||View DVAX Short Pain Metrics - ShortPainBot.com|
|View DVAX Stock Mentions - StockTwits||View DVAX Stock Mentions - PennyStockTweets|
|View DVAX Stock Mentions - Twitter||View DVAX Investment Forum News - Investor Hub|
|View DVAX Stock Mentions - Yahoo! Message Board||View DVAX Stock Mentions - Seeking Alpha|
|View Insider Transactions for DVAX - SECform4.com||View Insider Transactions for DVAX - Insider Cow|
|View DVAX Major Holdings Summary - CNBC||View Insider Disclosure for DVAX - OTC Markets|
|View Insider Transactions for DVAX - Yahoo! Finance||View Institutional Holdings for DVAX - NASDAQ|
|View DVAX Stock Insight & Charts - FinViz.com||View DVAX Investment Charts - StockCharts.com|
|View DVAX Stock Overview & Charts - BarChart||View DVAX User Generated Charts - Trading View|
Dynavax Announces Publication of Preclinical Study of TLR9 Agonist in Lung Cancer
Posted on Tuesday September 04, 2018
Dynavax Technologies Corporation (DVAX) today announced publication of a preclinical study demonstrating that inhalation of a TLR9 agonist can stimulate effective immunity against lung tumors and complement the actions of PD-1 blockade to generate durable, systemic anti-tumor immunity. The paper titled Inhaled TLR9 Agonist Renders Lung Tumors Permissive to PD-1 Blockade by Promoting Optimal CD4+ and CD8+ T cell Interplay, by Dynavax scientists M.Gallotta, H. Assi, E. Degagné, S. Kannan, R.Coffman and C. Guiducci was published in the journal Cancer Research.
Dynavax Technologies Corporation (DVAX) today announced that two peer-reviewed papers reporting clinical studies of SD-101 have been published by Cancer Discovery, a journal publication from American Association of Cancer Research (AACR). The investigators report clinical activity and broad immune activation in the tumor microenvironment when SD-101 is administered in combination with either low dose radiation in patients with indolent lymphoma or in combination with PD-1 blockade in patients with unresectable or metastatic melanoma. “Promising data from multiple trials studying intratumoral administration of TLR9 agonists indicate that stimulating the innate immune system through the TLR9 pathway can enhance the adaptive immune response to both injected and non-injected tumors,” said Antoni Ribas, M.D., Ph.D., Director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center.
Is Dynavax Technologies Corporation a Buy?
Posted on Sunday August 19, 2018
A slow launch for its hepatitis B vaccine has hurt Dynavax. But are better days ahead?
Edited Transcript of DVAX earnings conference call or presentation 6-Aug-18 8:30pm GMT
Posted on Friday August 17, 2018
Q2 2018 Dynavax Technologies Corp Earnings Call